of the North Caucasus
Series ПИ #ФС 77-26521.
Federal service for surveillance over non-violation of the legislation in the sphere of mass communications and protection of cultural heritage.
ISSN 2073-8137
русский
english
Site search
Correspondence address
310 Mira Street, Stavropol, Russia, 355017
Tel
+7 865 2352511, +7 865 2353229.
E-mail
medvestnik@stgmu.ru
The journal is included into The list of leading scientific periodicals.
The journal is included into VINITI database and is registered in Electronic scientific library.
The journal is indexed by SCOPUS, Ulrich's International Periodicals Directory.
Migraine and anxiety-depressive disorders
[Reviews]
Naida Isagadzhievna Garabova; Ellina Evgenievna Trube; Ekaterina Alekseevna Kirillova; Elizaveta Semina; Magomedova Inessa Gadzhievna;
Migraine is one of the most common causes of headaches, which significantly decreases the quality of life of people; it affects women after puberty more often and, due to difficulties in diagnosis and patient adherence, is underdiagnosed in men. Migraine is also associated with psychiatric disorders, especially anxiety and depression, which can worsen migraine severity and prognosis. Research shows a close relationship between chronic migraine and anxiety disorders due to the common pathogenesis; consequently, early evaluation and effective multidisciplinary treatments promote a holistic approach to neurological and mental health management.
References:
1. Alwhaibi M., Balkhi B., AlRuthia Y. Anxiety and depression and health-related quality of life among adults with migraine: a National Population-Based Study. Frontiers In Public Health. 2023;11:1241800. https://doi.org/10.3389/fpubh.2023.1241800
2. Duan S., Ren Z., Xia H., Wang Z., Zheng T. [et al.]. Associations between anxiety, depression with migraine, and migraine-related burdens. Frontiers In Neurology. 2023;14:1090878. https://doi.org/10.3389/fneur.2023.1090878
3. Kumar R., Asif S., Bali A., Dang A. K., Gonzalez D. A. The Development and Impact of Anxiety With Migraines: A Narrative Review. Cureus. 2022;14(6):e26419. https://doi.org/10.7759/cureus.26419
4. Ornello R., Andreou A. P., De Matteis E., Jürgens T. P., Minen M. T. [et al.]. Resistant and refractory migraine: clinical presentation, pathophysiology, and management. EBioMedicine. 2024;99:104943. https://doi.org/10.1016/j.ebiom.2023.104943
5. Ruscheweyh R., Lehnen N., Henningsen P. Migräne und psychosomatische Komorbiditäten [Migraine and psychosomatic comorbidity]. Fortschritte Der NeurologiePsychiatrie. 2024;92(7-08):304-309. https://doi.org/10.1055/a-2331-0840
6. Karimi L., Wijeratne T., Crewther S. G., Evans A. E., Ebaid D. [et al.]. The Migraine-Anxiety Comorbidity Among Migraineurs: A Systematic Review. Frontiers In Neurology. 2021;11:613372. https://doi.org/10.3389/fneur.2020.613372
7. Wachowska K., Bliźniewska-Kowalska K., Sławek J., Adamczyk-Sowa M., Szulc A. [et al.]. Common pathomechanism of migraine and depression. Wspólny patomechanizm migreny i depresji. Psychiatria Polska. 2023;57(2):405-419. https://doi.org/10.12740/PP/OnlineFirst/143982
8. de Vries Lentsch S., Louter M. A., van Oosterhout W., van Zwet E. W., van Noorden [et al.]. Depressive symptoms during the different phases of a migraine attack: A prospective diary study. Journal of Affective Disorders. 2022;297:502-507. https://doi.org/10.1016/j.jad.2021.10.046
9. Frimpong-Manson K., Ortiz Y. T., McMahon L. R., Wilkerson J. L. Advances in understanding migraine pathophysiology: a bench to bedside review of research insights and therapeutics. Frontiers in Molecular Neuroscience. 2024;17:1355281. https://doi:10.3389/fnmol.2024.1355281
10. Asif N., Patel A., Vedantam D., Poman D. S., Motwani L. Migraine With Comorbid Depression: Pathogenesis, Clinical Implications, and Treatment. Cureus. 2022;14(6):e25998. https://doi.org/10.7759/cureus.25998
11. Grangeon L., Lange K. S., Waliszewska-Prosół M., Onan D., Marschollek K. [et al.]. Genetics of migraine: where are we now? The Journal of Headache and Pain. 2023;24(1):12. https://doi.org/10.1186/s10194-023-01547-8
12. Kaag Rasmussen M., Møllgård K., Bork P. A. R., Weikop P., Esmail, T. [et al.]. Trigeminal ganglion neurons are directly activated by influx of CSF solutes in a migraine model. Science. 2024;385(6704):80-86. https://doi.org/10.1126/science.adl0544
13. Parajulee A., Kim K. Structural studies of serotonin receptor family. BMB Reports. 2023;56(10):527-536. https://doi.org/10.5483/BMBRep.2023-0147
14. Kitamura E., Imai N. Molecular and Cellular Neurobiology of Spreading Depolarization/Depression and Migraine: A Narrative Review. International Journal of Molecular Sciences. 2024;25(20):11163. https://doi.org/10.3390/ijms252011163
15. Androulakis X. M., Yu X., Zhu X., Thiam M. A., Cai G. Migraine and major depression: localizing shared genetic susceptibility in different cell types of the nervous systems. Frontiers in Neurology. 2023;14:1254290. https://doi.org/10.3389/fneur.2023.1254290
16. Eren-Koçak E., Dalkara T. Ion Channel Dysfunction and Neuroinflammation in Migraine and Depression. Frontiers in Pharmacology. 2021;12:777607. https://doi.org/10.3389/fphar.2021.777607
17. Viudez-Martínez A., Torregrosa A. B., Navarrete F., GarcíaGutiérrez M. S. Understanding the Biological Relationship between Migraine and Depression. Biomolecules. 2024;14(2):163. https://doi.org/10.3390/biom14020163
18. Pistoia F., Salfi F., Saporito G., Ornello R., Frattale I. [et al.]. Behavioral and psychological factors in individuals with migraine without psychiatric comorbidities. The Journal of Headache and Pain. 2022;23(1):110. https://doi.org/10.1186/s10194-022-01485-x
19. Torres-Ferrús M., Ursitti F., Alpuente A., Brunello F., Chiappino D. [et al.]. From transformation to chronification of migraine: pathophysiological and clinical aspects. The Journal of Headache and Pain. 2020;21(1):42. https://doi.org/10.1186/s10194-020-01111-8
20. Amiri P., Kazeminasab S., Nejadghaderi S. A., Mohammadinasab R., Pourfathi H. [et al.]. Migraine: A Review on Its History, Global Epidemiology, Risk Factors, and Comorbidities. Front. Neurol. 2022;12:800605. https://doi.org/10.3389/fneur.2021.800605
21. Lv X., Xu B., Tang X., Liu S., Qian J. H. [et al.]. The relationship between major depression and migraine: A bidirectional two-sample Mendelian randomization study. Frontiers in Neurology. 2023;14:1143060. https://doi.org/10.3389/fneur.2023.1143060
22. Sanchez Del Rio M., Cutrer F. M. Pathophysiology of migraine aura. Handbook of Clinical Neurology. 2023;198:71-83. https://doi.org/10.1016/B978-0-12-823356-6.00016-0
23. Alwhaibi M., Meraya A. M., AlRuthia, Y. Healthcare Expenditures Associated With Comorbid Anxiety and Depression Among Adults With Migraine. Frontiers in Neurology. 2021;12:658697. https://doi.org/10.3389/fneur.2021.658697
24. Stubberud A., Buse D. C., Kristoffersen E. S., Linde M., Tronvik E. Is there a causal relationship between stress and migraine? Current evidence and implications for management. The Journal of Headache and Pain. 2021;22(1):155. https://doi.org/10.1186/s10194-021-01369-6
25. Affatato O., Dahlén A. D., Rukh G., Schiöth H. B., Mwinyi J. Assessing volumetric brain differences in migraine and depression patients: a UK Biobank study. BMC neurology. 2023;23(1):284. https://doi.org/10.1186/s12883-023-03336-x
26. Li Y., Luo G., Zhou L., Wang X., Liu H. [et al.]. Mediators of the association between depression and migraine: a mendelian randomization study. Frontiers in Genetics. 2024;15:1326817. https://doi.org/10.3389/fgene.2024.1326817
27. David M. C. M. M., Mattos M. S. B., Souto J. J. S., Brito S. A. C. F., Leite E. S. [et al.]. Changes in the rest-activity rhythm in migraine patients are associated with anxiety symptoms. Revista Brasileira de Psiquiatria. 2022;44(6):611-620. https://doi.org/10.47626/1516-4446-2021-2367
28. Cacciatore M., Raggi A., Pilotto A., Cristillo V., Guastafierro E. [et al.]. Neurological and Mental Health Symptoms Associated with Post-COVID-19 Disability in a Sample of Patients Discharged from a COVID-19 Ward: A Secondary Analysis. International Journal of Environmental Research and Public Health. 2022;19(7):4242. https://doi.org/10.3390/ijerph19074242
29. Suzuki K., Takeshima T., Igarashi H., Imai N., Danno D. [et al.]. Impact of the COVID-19 pandemic on migraine in Japan: a multicentre cross-sectional study. The Journal of Headache and Pain. 2021;22(1):53. https://doi.org/10.1186/s10194-021-01263-1
30. Hrytsenko O., Kopchak O., Kozyk M., Strubchevska K. The impact of the COVID-19 pandemic on patients with migraine. SAGE Open Medicine. 2023;11:20503121231170726. https://doi.org/10.1177/20503121231170726
31. Magdy R., Elmazny A., Soliman S. H., Elsebaie E. H., Ali S. H. [et al.]. Post-COVID-19 neuropsychiatric manifestations among COVID-19 survivors suffering from migraine: a case-control study. The Journal of Headache and Pain. 2022;23(1):101. https://doi.org/10.1186/s10194-022-01468-y
32. Irimia P., Garrido-Cumbrera M., Santos-Lasaosa S., Aguirre-Vazquez M., Correa-Fernández J. [et al.]. Impact of monthly headache days on anxiety, depression and disability in migraine patients: results from the Spanish Atlas. Scientific Reports. 2021;11(1):8286. https://doi.org/10.1038/s41598-021-87352-2
33. Lee H., Kim S., Chang M. C. Associations Between Headache (Migraine and Tension-Type Headache) and Psychological Symptoms (Depression and Anxiety) in Pediatrics: A Systematic Review and Meta-analysis. Pain Physician. 2023;26(6):617-626.
34. Zhu J., Chen J., Zhang K. Clinical effect of flunarizine combined with duloxetine in the treatment of chronic migraine comorbidity of depression and anxiety disorder. Brain and Behavior. 2022;12(8):e2689. https://doi.org/10.1002/brb3.2689
35. de Vries Lentsch S., van der Arend B. W. H., de Boer I., van Zwet E. W., MaassenVanDenBrink A. [et al.]. Depression and treatment with anti-calcitonin gene related peptide (CGRP) (ligand or receptor) antibodies for migraine. European Journal of Neurology. 2024;31(2):e16106. https://doi.org/10.1111/ene.16106
36. Chen S. P. Migraine and treatment-resistant depression. Progress in Brain Research. 2023;281:149-173. https://doi.org/10.1016/bs.pbr.2023.05.001
37. Omaer A., Albilali A., Bamogaddam R., Almutairi F., Alsaif R. [et al.]. Improvement of comorbid anxiety and depression in patients with migraine treated with injectable preventive calcitonin gene-related peptide antagonists: Review of clinical evidence. Saudi pharmaceutical journal: SPJ: the official publication of the Saudi Pharmaceutical Society. 2024;32(4):101989. https://doi.org/10.1016/j.jsps.2024.101989
38. Caronna E., Alpuente A., Torres-Ferrus M., Pozo-Rosich P. CGRP monoclonal antibodies and CGRP receptor antagonists (Gepants) in migraine prevention. Handbook of Clinical Neurology. 2024;199:107-124. https://doi.org/10.1016/B978-0-12-823357-3.00024-0
39. Hervias T. An update on migraine: Current and new treatment options. JAAPA. 2024;37(5):1-7. https://doi.org/10.1097/01.JAA.0000000000000014
40. Mollan S. P., Subramanian A., Perrins M., Nirantharakumar K., Adderley N. J. [et al.]. Depression and anxiety in women with idiopathic intracranial hypertension compared to migraine: A matched controlled cohort study. Headache. 2023;63(2):290-298. https://doi.org/10.1111/head.14465
41. Lee W., Shin H. J., Min I. K., Kim C. S., Kim K. M. [et al.]. Shared comorbidity of depression, migraine, insomnia, and fibromyalgia in a population-based sample. Journal of Affective Disorders. 2024;354:619-626. https://doi.org/10.1016/j.jad.2024.03.077
42. McCracken H. T., Thaxter L. Y., & Smitherman T. A. Psychiatric comorbidities of migraine. Handbook of Clinical Neurology. 2024;199:505-516. https://doi.org/10.1016/B978-0-12-823357-3.00013-6
43. Demır Ü. F., Bozkurt O. Effects of Perceived Social Support, Depression and Anxiety Levels on Migraine. Noro Psikiyatri Arsivi. 2020;57(3):210-215. https://doi.org/10.29399/npa.25000
44. Pearl T. A., Dumkrieger G., Chong C. D., Dodick D. W., Schwedt T. J. Impact of Depression and Anxiety Symptoms on Patient-Reported Outcomes in Patients With Migraine: Results From the American Registry for Migraine Research (ARMR). Headache. 2020;60(9):1910-1919. https://doi.org/10.1111/head.13911
Keywords: migraine, depression, anxiety, headache and anxiety-depressive disorders
Founders:
Stavropol State Medical Academy
Pyatigorsk State Research Institute of Balneotherapeutics
Pyatigorsk State Pharmaceutical Academy